Agreed ...HXL sp will reflect the progression through trials , results
are about to be announced ...also as indicated in your video above..
that a new application for pezadeftide will be announced ...looks promising..
Wilson's report... based on success through to phase 3.. have forecasted a
sp ...$2.48....
fyi...the Presentation at American Academy of Dermatology March 2022
is available on HXL website ...
https://hexima.com.au/presentation-at-american-academy-of-dermatology-march-2022/
the actual presentation's here
https://hexima.com.au/wp-content/uploads/2022/03/Hexima_AAD2022_pezadeftide_MOA_presentation_8.pdf
glta...
Interview with Michael Adridge, page-4
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add HXL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $2.004M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 500000 | 1.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.2¢ | 450000 | 1 |
View Market Depth
| Last trade - 16.12pm 22/07/2024 (20 minute delay) ? |
| HXL (ASX) Chart |
Day chart unavailable